This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Hermès International Société en commandite par actions ( HERM:CA) Shareholder/Analyst Call April 17, 2026 3:30 AM EDT ...

Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...

Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today presented new global, real-world, patient-centric data, including data from a study assessing the impacts on quality of life ...

Seven abstracts represent data across migraine, childhood-onset epilepsy and multiple system atrophy (MSA), highlighting Lundbeck's biology-driven approach to developing treatments for serious brain ...

Estonia is set to receive about €6.5 billion from a fund that is part of the European Union's long-term budget, but ...

What happens when this doctor goes keto and his LDL rockets to 574? We dive deep into the science, controversy, and personal ...

Tick, tick, tick, tick.” I stare up at the clock during fourth period, impatiently waiting for it to be 12:14 p.m. so I can ...

Conservation levels of gene expression abundance ratios are globally coordinated in cells, and cellular state changes under such biologically relevant stoichiometric constraints are readable as ...

SurgePays, Inc. (NASDAQ: SURG) ("SurgePays" or the "Company"), a wireless and fintech technology company connecting subprime and underserved consumers ...